APS plays foundational role in development of COVID-19 vaccines More than a decade of virus research at the APS laid the groundwork for more effective COVID-19 vaccines and helped speed their rapid development.
100th structure of COVID-19 virus from Advanced Photon Source data released The APS has been a powerful tool in the battle against the novel coronavirus, contributing more information about the structure of the virus to the International Protein Databank than any other light source in the United States.
Texas Restaurant Association Partners With Integrated Viral Protection to Re-open Restaurants and Businesses
Argonne epidemiological supercomputing model showcases innovation CityCOVID, a model demonstrating the interactions between “agents” during COVID, was nominated for an ACM Gordon Bell prize.
The AI-driven initiative that’s hastening the discovery of drugs to treat COVID-19 A novel pipeline of AI and simulation tools may make the process of screening drug candidates for COVID-19 50,000 times faster.